KEVIN P STARR Insider Trading $BPMC Blueprint Medicines Corp

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for KEVIN P STARR.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of KEVIN P STARR. KEVIN P STARR is Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Director in ZAFGEN, INC. ($ZFGN) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in MyoKardia Inc ($MYOK) and 10% Owner in Blueprint Medicines Corp ($BPMC) and in Sage Therapeutics, Inc. ($SAGE) and Director in Sage Therapeutics, Inc. ($SAGE) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and Director in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Editas Medicine, Inc. ($EDIT).

KEVIN P STARR in Blueprint Medicines Corp

Trading Symbol: BPMC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KEVIN P STARR: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 21 2016
$BPMC Market Capitalization: $979.55M
$BPMC Previous Close: $35.84

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of KEVIN P STARR in Blueprint Medicines Corp

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALNY, BPMC, CTMX, EDIT, GBT, LRMR, MYOK, SAGE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 21 2016BPMCBlueprint Medicine ...STARR KEVIN P10% OwnerSellS28.19106,4893,002,3510106.5 K to 0 (-100.00 %)

Page:   1